Biotech Distilled
Substack ↗ Subscribe
Subscribe Substack ↗ About

Home › Therapeutic areas › Respiratory

Respiratory (20 companies · 9 conditions)

Conditions

Asthma 5 Idiopathic Pulmonary Fibrosis 4 Rare Acute Respiratory Distress Syndrome 3 Alpha-1 Antitrypsin Deficiency 3 Rare COPD 3 Cystic Fibrosis 3 Rare Bronchiectasis 1 Obstructive Sleep Apnea 1 Progressive Pulmonary Fibrosis 1 Rare

Companies

Ticker Company Therapeutic areas In Respiratory Lead stage Programs
FDMT 4D Molecular Therapeutics OphthalmologyRespiratory Rare 2 Phase 3 5
ACRS Aclaris Therapeutics DermatologyGI/Hepatology+1 Rare 1 Phase 2 8
AGMB Agomab Therapeutics ImmunologyRespiratory Rare 1 Phase 2 4
AKBA Akebia Therapeutics HematologyOphthalmology+2 Rare 1 Approved 10
APGE Apogee Therapeutics DermatologyGI/Hepatology+1 Rare 4 Phase 2 9
BEAM Beam Therapeutics HematologyMetabolic+1 Rare 1 Phase 2 6
CLDX Celldex Therapeutics DermatologyImmunology+1 1 Phase 3 7
CNTB Connect Biopharma Respiratory 4 Phase 2 4
IXHL Incannex Healthcare ImmunologyNeurology+1 1 Phase 2 3
INSM Insmed CardiovascularDermatology+2 Rare 3 Approved 9
KYMR Kymera Therapeutics DermatologyRespiratory Rare 1 Phase 2 4
INKT MiNK Therapeutics ImmunologyOncology+1 Rare 1 Phase 2 7
OMER Omeros HematologyNeurology+2 Rare 1 Approved 6
RVPH Reviva Pharmaceuticals CardiovascularDermatology+2 Rare 1 Phase 3 10
SRPT Sarepta Therapeutics NeurologyRespiratory Rare 1 Approved 10
SION Sionna Therapeutics Respiratory Rare 5 Phase 2 5
GPCR Structure Therapeutics MetabolicRespiratory Rare 1 Phase 3 5
VTVT vTv Therapeutics MetabolicRespiratory Rare 1 Phase 3 8
WVE Wave Life Sciences MetabolicNeurology+1 Rare 1 Phase 2 5
ZYME Zymeworks OncologyRespiratory 1 Approved 11